The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3,4-dichlorophenyl)-7-(pyridin-4-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepine-4(5H)-carboxamide ID: ALA4782723
PubChem CID: 162664099
Max Phase: Preclinical
Molecular Formula: C21H18Cl2N4O
Molecular Weight: 413.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(Cl)c(Cl)c1)N1CCNc2ccc(-c3ccncc3)cc2C1
Standard InChI: InChI=1S/C21H18Cl2N4O/c22-18-3-2-17(12-19(18)23)26-21(28)27-10-9-25-20-4-1-15(11-16(20)13-27)14-5-7-24-8-6-14/h1-8,11-12,25H,9-10,13H2,(H,26,28)
Standard InChI Key: YKVVIEAZGZVHCN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
3.7337 -9.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7326 -9.9778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4406 -10.3868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4388 -8.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0264 -10.3861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3188 -9.9753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6112 -10.3826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6101 -11.2007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3225 -11.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0271 -11.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1522 -9.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1475 -9.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7884 -8.6338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8023 -10.4846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5929 -8.8064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6053 -10.2933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9542 -9.5457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1216 -10.9268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8312 -11.6906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9283 -10.7963 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4446 -11.4297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1515 -12.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6671 -12.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4747 -12.6950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7641 -11.9263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2467 -11.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5704 -11.7930 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.9919 -13.3278 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 11 2 0
12 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 5 1 0
11 12 1 0
12 13 1 0
11 14 1 0
13 15 1 0
14 16 1 0
15 17 1 0
16 17 1 0
16 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
25 27 1 0
24 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 413.31Molecular Weight (Monoisotopic): 412.0858AlogP: 5.52#Rotatable Bonds: 2Polar Surface Area: 57.26Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.10CX Basic pKa: 5.30CX LogP: 3.99CX LogD: 3.99Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.64
References 1. Wilson JE,Kurukulasuriya R,Sinz C,Lombardo M,Bender K,Parker D,Sherer EC,Costa M,Dingley K,Li X,Mitelman S,Tong S,Bugianesi R,Ehrhardt A,Priest B,Ratliff K,Ujjainwalla F,Nargund R,Hagmann WK,Edmondson S. (2016) Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes., 26 (12.0): [PMID:27240550 ] [10.1016/j.bmcl.2016.04.018 ]